WT161 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor targeting specific pathways involved in tumor growth and proliferation. Researchers employ WT161 to investigate its efficacy in inducing apoptosis in cancer cells, thereby exploring its potential as a therapeutic agent. Additionally, it is used in preclinical studies to understand its mechanism of action and to assess its impact on various cancer models. The compound is also valuable in drug development processes, where it aids in the identification and validation of new targets for cancer treatment. Overall, WT161 plays a crucial role in advancing oncology research and the development of novel anticancer drugs.